Propeller Health is partnering with Aptar Pharma, a drug delivery system company, to create what the company believes will be the first-to-market integrated, connected metered dose inhaler (MDI).

PORTLAND, Ore., Nov. 26, 2025 /PRNewswire/ -- Summary: Metered Dose Inhalers (MDIs) are widely used in the treatment and management of respiratory conditions such as asthma and chronic obstructive ...

NEW YORK, Dec. 5, 2017 /PRNewswire/ -- Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and ...

GSK plc announced positive phase III data from its clinical programme to develop a next-generation version of its metered dose inhaler (MDI), Ventolin (salbutamol). Data confirm that the formulation ...

Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...

NEW ORLEANS — Switching inhaler types due to insurance formulary changes may lead to reduced lung function in children with asthma, according to data presented at the CHEST Annual Meeting. “Insurance ...

The research team, including scientists from the University of California Los Angeles, found that metered-dose inhalers -- those containing hydrofluoroalkane (HFA) propellants and releasing aerosols - ...

For the 25 million Americans with asthma, inhalers can be a lifeline. But those puffs can hurt the planet. "About three quarters of all inhalers used in the in this country are propellant-type ...

New reports reveal the most commonly prescribed inhaler in the U.S. may actually be contributing to climate change. While these inhalers are critically important to saving lives and making it easier ...